Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Adjuvant Anticancer Effect in Biliary-pancreas Cancer
NCT01111591Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2008
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of celecoxib in extrahepatic bile duct cancer, pancreatic cancer (PC), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
celecoxib
03
Conditions
extrahepatic bile duct cancerpancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01111591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01111591.